Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity

Area of Science:

• Pediatric medicine
• Pharmacological treatment
• Healthcare quality improvement

Background:

• Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder requiring ongoing management.
• Medication adherence and continuity of care are critical for effective ADHD treatment in children.
• Understanding the impact of physician practices on medication use is essential for optimizing patient outcomes.

Purpose of the Study:

• To examine the association between physician care practices and subsequent medication use in children with ADHD.
• To identify specific physician behaviors that influence medication supply and treatment continuity.
• To evaluate the relationship between the quality of ADHD care and medication adherence.

Main Methods:

• Retrospective cohort study of 1,352 children initiating ADHD medication across 50 pediatric practices.
• Analysis of physician behaviors including medication titration and response monitoring.
• Statistical modeling (multilevel and Cox regression) to assess outcomes like medication days supplied and gaps in supply.

Main Results:

• Children received an average of 217 days of ADHD medication supply in the first year.
• Half of children experienced a 30-day medication gap within the first 3 months.
• Earlier physician contact and medication adjustments were linked to improved medication supply and continuity.

Conclusions:

• Prompt physician engagement and timely medication adjustments in ADHD care enhance medication supply and continuity.
• Further research is needed to determine if interventions improving titration and monitoring practices can further boost medication continuity.
• Optimizing physician-led ADHD care practices is crucial for sustained treatment adherence.